Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Total Current Liabilities: 2021-2022

Historic Total Current Liabilities for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to $6.5 million.

  • Milestone Pharmaceuticals' Total Current Liabilities rose 11.54% to $6.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.5 million, marking a year-over-year increase of 11.54%. This contributed to the annual value of $6.8 million for FY2021, which is N/A change from last year.
  • As of Q3 2022, Milestone Pharmaceuticals' Total Current Liabilities stood at $6.5 million, which was up 53.24% from $4.3 million recorded in Q2 2022.
  • In the past 5 years, Milestone Pharmaceuticals' Total Current Liabilities registered a high of $6.8 million during Q4 2021, and its lowest value of $4.3 million during Q2 2022.
  • In the last 2 years, Milestone Pharmaceuticals' Total Current Liabilities had a median value of $5.8 million in 2021 and averaged $5.6 million.
  • Within the past 5 years, the most significant YoY rise in Milestone Pharmaceuticals' Total Current Liabilities was 11.54% (2022), while the steepest drop was 20.74% (2022).
  • Milestone Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $6.8 million in 2021, then climbed by 11.54% to $6.5 million in 2022.
  • Its Total Current Liabilities was $6.5 million in Q3 2022, compared to $4.3 million in Q2 2022 and $4.6 million in Q1 2022.